Study of Body Composition, Lung Function, and Quality of Life Following Use of Anabolic Steroids in Patients With Chronic Obstructive Pulmonary Disease. (19th February 2014)

• Record Type: Journal Article
• Authors: Daga, Mradul Kumar; Khan, Naushad Ahmad; Malhotra, Varun; Kumar, Suman; Mawari, Govind; Hira, Harmanjit Singh
• Is Part Of: Nutrition in clinical practice. Volume 29:Number 2(2014:Apr.)
• Page Start: 238
• Page End: 245
• Publication Date: 2014-02-19
• Subjects: chronic obstructive pulmonary disease -- anabolic agents -- nandrolone -- nutrition -- nutrition assessment; Nutrition -- Periodicals; Diet therapy -- Periodicals; Artificial feeding -- Periodicals; 615.854
• DOI: 10.1177/0884533614522832
• Languages: English
• ISSNs: 0884-5336

Abstract

Abstract : Background : Chronic obstructive pulmonary disease (COPD) is characterized by irreversible airflow limitation and is associated with weight loss and decreased muscle strength and exercise capacity. Methods : A double‐blinded randomized controlled trial of 32 male COPD patients (age, 54.94 ± 11.27 years) was carried out to assess effects of anabolic steroid in terms of a daily high‐protein, high‐calorie diet alone or one combined with anabolic steroids on body composition, lung function, and health‐related quality of life (HRQL). Outcomes were assessed by anthropometric and spirometric measurements, peak expiratory flow rate, partial pressure of oxygen in arterial blood, 6‐minute walk test (6MWT), hand grip test, and HRQL index scores. Measurements were made at baseline and end of treatment (6 weeks). Results : All patients showed significant difference ( P < .001) in pulmonary function parameters and anthropometric measurements after 6 weeks of intervention (within‐group changes); however, no significant improvement occurred in the pulmonary function parameters between the groups. The difference in exercise capacity (6MWT) and HRQL scores in the treatment group were statistically significant ( P < .001) compared with control group after 6 weeks of intervention. In the treatment group, the average 6MWT distance increased from 213.5 m to 268.5 m at 6‐week follow‐up, and HRQL scores increased from 101.25 to 118.45. Also, HRQL and 6MWT parameters were positively correlated in response to steroid supplementation at the end of the study. Conclusion : Weekly administration of anabolic steroids during 6 weeks increased exercise capacity and quality of life in patients with COPD.